Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Prothena Corporation PLC (NASDAQ:PRTA)

46.03
Delayed Data
As of 1:00pm ET
 +0.18 / +0.39%
Today’s Change
44.43
Today|||52-Week Range
70.00
-6.42%
Year-to-Date
Acorda Stock Up Despite Phase III Trial on Tozadenant Stops
Nov 21 / Zacks.com - Paid Partner Content
Acorda Reports Death in Parkinson's Trials, Stock Down 40%
Nov 16 / Zacks.com - Paid Partner Content
Cytokinetics Shares Plunge on Study Results for ALS Drug -- Biotech Movers
Nov 21 / TheStreet.com - Paid Partner Content